Skip to main content
Log in

Mitochondria-Associated Matrix Metalloproteinases 2 and 9 in Acute Renal Pathologies

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Activities of MMP-2 and MMP-9 in the cytoplasm and mitochondria of kidney cells were evaluated on the models of acute renal pathologies: pyelonephritis, rhabdomyolysis, and ischemia/reperfusion of the kidney. In acute pyelonephritis, a significant increase in the level of MMP-2 and MMP-9 in kidney cells and the appearance of mitochondrial MMP-2 isoform with a lower molecular weight, but still exhibiting proteolytic activity were observed. A direct correlation between the level of MMP-2 and MMP-9 in the kidney and the severity of inflammation in pyelonephritis was revealed. Obviously, the appearance of active protease in the mitochondria of the kidney cells could have an impact on their functioning and, generally, on the fate of renal cells in this pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kirpatovskii VI, Kazachenko AV, Plotnikov EY, Kon’kova TA, Drozhzheva VV, Zorov DB. Effects of ischemic and hypoxic preconditioning on the state of mitochondria and function of ischemic kidneys. Bull. Exp. Biol. Med. 2007;143(1):105-109.

    Article  CAS  PubMed  Google Scholar 

  2. Kushlinskii NE, Timofeev YS, Solov’ev YN, Gerstein ES, Lyubimova NV, Bulycheva IV. Components of the RANK/RANKL/OPG system, IL-6, IL-8, IL-16, MMP-2, and calcitonin in the sera of patients with bone tumors. Bull. Exp. Biol. Med. 2014;157(4):520-523.

    Article  CAS  PubMed  Google Scholar 

  3. Ali MA, Fan X, Schulz R. Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease. Trends Cardiovasc. Med. 2011;21(4):112-118.

    Article  CAS  PubMed  Google Scholar 

  4. Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, Dahi S, Karliner JS, Lovett DH. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2007;292(4):H1847-H1860.

    Article  CAS  PubMed  Google Scholar 

  5. Coker ML, Doscher MA, Thomas CV, Galis ZS, Spinale FG. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am. J. Physiol. 1999;277(2, Pt 2): H777-H787.

    CAS  PubMed  Google Scholar 

  6. Kandasamy AD, Chow AK, Ali MA, Schulz R. Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc. Res. 2010;85(3):413-423.

    Article  CAS  PubMed  Google Scholar 

  7. Kaneko T, Shimizu A, Mii A, Fujita E, Fujino T, Kunugi S, Du X, Akimoto T, Tsuruoka S, Ohashi R, Masuda Y, Iino Y, Katayama Y, Fukuda Y. Role of matrix metalloproteinase-2 in recovery after tubular damage in acute kidney injury in mice. Nephron Exp. Nephrol. 2012;122(1-2):23-35.

    Article  CAS  PubMed  Google Scholar 

  8. Kluger MA, Zahner G, Paust HJ, Schaper M, Magnus T, Panzer U, Stahl RA. Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis. Kidney Int. 2013;83(5):865-877.

    Article  CAS  PubMed  Google Scholar 

  9. Lovett DH, Mahimkar R, Raffai RL, Cape L, Maklashina E, Cecchini G, Karliner JS. A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity. PLoS One. 2012;7(4):e34177. doi: https://doi.org/10.1371/journal.pone.0034177.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am. J. Physiol. Renal Physiol. 2012; 302(11):F1351-F1361.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Vandooren J, Geurts N, Martens E, Van den Steen PE, Opdenakker G. Zymography methods for visualizing hydrolytic enzymes. Nat. Methods. 2013;10(3):211-220.

    Article  CAS  PubMed  Google Scholar 

  12. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation. 2002;106(12):1543-1549.

    Article  CAS  PubMed  Google Scholar 

  13. Zhao H, Dong Y, Tian X, Tan T.K, Liu Z, Zhao Y, Zhang Y, Harris DCh, Zheng G. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World J. Nephrol. 2013;2(3):84-89.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Zhou HZ, Ma X, Gray MO, Zhu BQ, Nguyen AP, Baker AJ, Simonis U, Cecchini G, Lovett DH, Karliner JS. Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Biochem. Biophys. Res. Commun. 2007;358(1):189-195.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. Yu. Plotnikov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 9, pp. 304-309, September, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pevzner, I.B., Zorova, L.D., Galkin, F.A. et al. Mitochondria-Associated Matrix Metalloproteinases 2 and 9 in Acute Renal Pathologies. Bull Exp Biol Med 166, 334–338 (2019). https://doi.org/10.1007/s10517-019-04345-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-019-04345-y

Key Words

Navigation